National Health Investors, Inc. (NYSE:NHI) Receives Consensus Rating of “Moderate Buy” from Brokerages

National Health Investors, Inc. (NYSE:NHI) has been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $85.5714.

A number of research firms have issued reports on NHI. Wells Fargo & Company boosted their price target on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 25th. National Bankshares set a $85.00 target price on shares of National Health Investors in a report on Tuesday, January 20th. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a research report on Monday, December 29th. KeyCorp boosted their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Finally, Truist Financial upped their price objective on National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research note on Monday, December 15th.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in National Health Investors by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock worth $516,624,000 after acquiring an additional 52,474 shares during the period. State Street Corp increased its stake in shares of National Health Investors by 5.0% in the second quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock worth $143,651,000 after purchasing an additional 95,812 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of National Health Investors by 34.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares during the period. Geode Capital Management LLC raised its position in shares of National Health Investors by 4.5% during the 2nd quarter. Geode Capital Management LLC now owns 1,232,524 shares of the real estate investment trust’s stock valued at $86,434,000 after purchasing an additional 53,630 shares during the period. Finally, Centersquare Investment Management LLC lifted its stake in shares of National Health Investors by 21.8% during the 3rd quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock valued at $78,443,000 after buying an additional 176,410 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Trading Up 0.8%

NYSE:NHI opened at $79.47 on Monday. The company has a market cap of $3.79 billion, a PE ratio of 25.07, a price-to-earnings-growth ratio of 2.72 and a beta of 0.67. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74. The company has a 50 day simple moving average of $78.11 and a two-hundred day simple moving average of $76.37. National Health Investors has a 12 month low of $65.22 and a 12 month high of $81.48.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.08. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The firm had revenue of $83.36 million for the quarter, compared to analysts’ expectations of $85.66 million. During the same period in the prior year, the firm earned $1.03 EPS. The company’s revenue was down 1.8% compared to the same quarter last year. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. Research analysts forecast that National Health Investors will post 4.41 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a $0.92 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. National Health Investors’s dividend payout ratio is presently 116.09%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.